Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MASTERPIECE: Microbiota Transplant Therapy for HE Recurrence in Cirrhosis
NCT07528690Phase 2Not yet recruiting
- Sponsor
- VA Office of Research & Development
- Start
- Oct 2026
- Primary completion
- Oct 2030
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of MTP-101 in hepatic encephalopathy (HE), sponsored by VA Office of Research & Development. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
MTP-101
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT07528690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07528690.